Literature DB >> 12028042

Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency.

Flora Peyvandi1, Marzia Menegatti, Elena Santagostino, Sepideh Akhavan, James Uprichard, David J Perry, Stephen J Perkins, Pier M Mannucci.   

Abstract

Factor X (FX) deficiency is a rare autosomal recessive disorder. The phenotype and genotype of 15 Iranian patients with FX deficiency from 13 unrelated families with a high frequency of consanguinity were analysed. Five different assays identified four patients from three families with a discrepancy between low-FX coagulant activity (FX:C) and higher-FX antigen (FX:Ag) (a type II deficiency). The remaining 11 patients had parallel reductions of FX:C and FX:Ag (a type I deficiency). Nine different homozygous candidate mutations were identified, of which eight were novel. The four type II cases were associated with an Arg(-1)Thr missense mutation in the prepropeptide: Arg(-1) is highly conserved in all vitamin K-dependent proteins. Four type I mutations (Gly78Asp, Cys81Tyr, Gly94Arg and Asp95Glu) were localized to the EGF-1 and EGF-2 domains, for which molecular views showed that the protein folding would be disrupted. The type I mutation Gly222Asp was localized in the catalytic domain of FX, and is sufficiently close to the Asp-His-Ser catalytic triad to disrupt its correct protein folding. The two type I splice site mutations were IVS1+3, A-->T and IVS2-3, T-->G. These novel homozygous FX mutations were consistent with their phenotypes and agree with experimental data from knockout mice, indicating that FX is an essential protein for survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028042     DOI: 10.1046/j.1365-2141.2002.03486.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

2.  Rare case of combined factor V and factor X deficiency in pregnancy: presenting as secondary postpartum haemorrhage in first pregnancy and successful outcome in second pregnancy.

Authors:  Aniket Kakade; Tushar Panchanadikar; Yashwant Kulkarni
Journal:  Obstet Med       Date:  2013-05-03

3.  Genome editing of factor X in zebrafish reveals unexpected tolerance of severe defects in the common pathway.

Authors:  Zhilian Hu; Yang Liu; Michael C Huarng; Marzia Menegatti; Deepak Reyon; Megan S Rost; Zachary G Norris; Catherine E Richter; Alexandra N Stapleton; Neil C Chi; Flora Peyvandi; J Keith Joung; Jordan A Shavit
Journal:  Blood       Date:  2017-06-02       Impact factor: 22.113

4.  A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu.

Authors:  Kenji Shinohara; Mayumi Adachi; Kumiko Matsui; Kazuhiro Matsuda; Satomi Nagaya; Eriko Morishita
Journal:  Int J Hematol       Date:  2008-02-13       Impact factor: 2.490

5.  Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.

Authors:  Tomoki Togashi; Satomi Nagaya; Masayuki Nagasawa; Makiko Meguro-Horike; Keiji Nogami; Yuta Imai; Kana Kuzasa; Akiko Sekiya; Shin-Ichi Horike; Hidesaku Asakura; Eriko Morishita
Journal:  Int J Hematol       Date:  2019-10-30       Impact factor: 2.490

6.  Successful treatment of a noninhibitory antibody-mediated acquired factor X deficiency in a patient with marginal-zone lymphoma.

Authors:  Annemarie Meenhuis; Rianne van Vliet; Francisca Hudig; Paula F Ypma; Martin R Schipperus; Martine J Hollestelle
Journal:  Clin Case Rep       Date:  2015-05-25

7.  Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines.

Authors:  Peter A Feldman
Journal:  Med Hypotheses       Date:  2022-01-03       Impact factor: 1.538

8.  Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree.

Authors:  Yuanzheng Feng; Jiewen Ma; Liang V Tang; Wenyi Lin; Yanyi Tao; Zhipeng Cheng; Yu Hu
Journal:  Genes (Basel)       Date:  2021-09-27       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.